1. Home
  2. RNAC

RNAC

Cartesian Therapeutics Inc.

Logo Cartesian Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Founded: 2007 Country:
United States
United States
Employees: N/A City: WATERTOWN
Market Cap: 344.8M IPO Year: 2016
Target Price: $51.00 AVG Volume (30 days): 42.6K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -49.80 EPS Growth: N/A
52 Week Low/High: $11.67 - $42.60 Next Earning Date: 05-02-2024
Revenue: $26,004,000 Revenue Growth: -76.53%
Revenue Growth (this year): 31.4% Revenue Growth (next year): 48.50%

Share on Social Networks: